ESE Seminar: “Engineering Quantum Processors in Silicon”

Zoom - Email ESE for Link jbatter@seas.upenn.edu

Across the globe, physicists in academia and industry alike are competing to be the first to build a scalable universal quantum computer. Amongst the multitudes of quantum computing architectures, solid-state quantum processors based on spins in silicon are emerging as a strong contender. Silicon is an ideal material to host spin qubits: it supports long […]

Horizon 2030: Engineering Life & Life in (Bio)Engineering (Panel Discussion)

https://upenn.zoom.us/j/96715197752

This panel discussion will immediately follow the Spring 2021 Grace Hopper Distinguished Lecture delivered by Dr. Jennifer Lewis (details here). This webinar will be held remotely via Zoom (check email or contact ksas@seas.upenn.edu for the link).

ESE Seminar: “Integrated Nonlinear and Quantum Photonic Devices”

Zoom - Email ESE for Link jbatter@seas.upenn.edu

Recent advances in nanofabrication technology have allowed for the realization of ultra-low loss nanophotonic waveguides and is opening up exciting opportunities for next-generation nonlinear photonic circuits with higher integration density, advanced functionalities, and ultralow energy consumption. Those features are critical for advancing photonic technologies in both classical and quantum domains. In this talk, I will […]

ESE Seminar: “Engineering (Useful) Quantum Systems”

Zoom - Email ESE for Link jbatter@seas.upenn.edu

Quantum technologies have the potential to revolutionize sensing, communication, and computation. To realize this potential, it will be necessary to scale the size and complexity of engineered quantum systems by several orders of magnitude, without sacrificing coherence or fidelity. Trapped ion qubits provide unparalleled coherence and are a leading platform for current small-scale quantum technology […]

ESE Seminar: “Harnessing Light-Matter Interaction for Photonic Quantum Technologies”

Zoom - Email ESE for Link jbatter@seas.upenn.edu

Photonic quantum technologies have a unique potential for applications such as large-scale quantum networks and quantum-enhanced sensing. Furthermore, photons provide new paradigms for quantum simulations and a testbed for benchmarking the advantage of quantum simulators over the classical ones. These applications demand novel resources such as efficient single-photon sources, large clusters of entangled photons, and […]

The Jack Keil Wolf Lecture: “Coordination of Distributed Energy Resources (DERs)”

Zoom - Email ESE for Link jbatter@seas.upenn.edu

DERs are small-scale energy resources that can generate electricity, such as roof-top solar PV, store electricity, such as Tesla’s Powerwall, or whose electricity consumption can be flexibly controlled, such as EV chargers, HVACs, water heaters, and large industrial fans. DERs are located behind the meters of electricity consumers, such as in homes, commercial building and […]

Keeping Up the Good Work: Honoring 40 Years of Excellence in Diversity

Heilmeier Hall (Room 100), Towne Building 220 South 33rd Street, Philadelphia, PA, United States

This year marks the 40th anniversary of Penn Engineering's diversity efforts and we invite you to join us on Friday, December 3, at 3:00 p.m. EST to celebrate Penn Engineering’s new Office of Diversity, Equity, and Inclusion (ODEI), formerly known as the Office of Minority Programs. We plan to meet in Heilmeier Hall (Towne 100) […]

PSOC@Penn Seminar: Leyuan Ma, PhD

Raisler Lounge (Room 225), Towne Building 220 South 33rd Street, Philadelphia, PA, United States

Physical Sciences in Oncology Center PSOC@Penn Spring 2022 Hybrid-Seminar Series Towne 225 / Raisler Lounge @ Noon (EST) For Zoom link , please contact manu@seas.upenn.edu

Herman P. Schwan Distinguished Lecture: “Nucleoside-modified mRNA-LNP therapeutics” (Drew Weissman, Perelman School of Medicine)

Bodek Lounge, Houston Hall 3417 Spruce St, Philadelphia, PA, United States

Vaccines prevent 4-5 million deaths a year making them the principal tool of medical intervention worldwide. Nucleoside-modified mRNA was developed over 15 years ago and has become the darling of the COVID-19 pandemic with the first 2 FDA approved vaccines based on it. These vaccines show greater than 90% efficacy and outstanding safety in clinical […]